Business Context and Reporting Period
This Form 8-K Current Report was filed by BiomX Inc. on May 27, 2026. The filing discloses the appointment of a new executive officer and the terms of the associated consulting agreement.
Key Financial Metrics
The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the compensation of the newly appointed officer:
- Monthly Fee: $11,900 (pro-rated from a base of $17,000 for a 70% engagement level).
- Performance Bonus: Up to 50% of the base fee actually paid, subject to Board-established milestones.
- Equity Award: 200,000 shares of common stock, subject to Board approval and the establishment of an equity incentive plan.
Material Changes
The primary material change is the appointment of Mr. Roy Rousso as Chief Business Officer, effective July 1, 2026. This represents a strategic addition to the executive team with over two decades of leadership experience in digital infrastructure and technology sectors.
Outlook, Risks, and Unusual Items
Management Commentary and Terms:
- Vesting Schedule: The 200,000 share award vests in three equal annual installments starting July 1, 2026.
- Acceleration Provisions: In the event of termination without cause or a change of control, the award vests in equal monthly installments over the three-year schedule, with an additional six months of service credited to accelerate vesting.
- Termination: The Company may terminate the agreement for cause immediately or without cause with 60 days' notice (or payment in lieu). Mr. Rousso may also terminate with 60 days' notice.
- Covenants: The agreement includes 12-month non-competition and non-solicitation clauses.
Risks and Contingencies: The equity award is contingent upon the Board's approval and the establishment of a Company equity incentive plan. No other risks or contingencies are disclosed in this specific filing.
Investor Verification Checklist
- Verify the establishment and terms of the Company equity incentive plan required for the 200,000 share award.
- Confirm the specific milestones and objectives established by the Board for the performance bonus calculation.
- Review the full text of the Consulting Agreement (Exhibit 10.1) for complete legal terms.
- Monitor future filings for the actual issuance of the equity award and any subsequent financial impact on the company's cash flow.